96 related articles for article (PubMed ID: 54438)
1. In vitro inhibition of cell-mediated cytotoxicity against syngeneic Friend virus-induced leukemia by immunoregulatory alpha globulin.
Glaser M; Ting CC; Herberman RB
J Natl Cancer Inst; 1975 Dec; 55(6):1477-9. PubMed ID: 54438
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated immunity to Friend virus-induced leukemia. III. Characteristics of secondary cell-mediated cytotoxic response.
Ting CC; Kirchner H; Rodrigues D; Park JY; Herberman RB
J Immunol; 1976 Jan; 116(1):244-52. PubMed ID: 54388
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated immunity to Friend virus-induced leukemia. II. Characteristics of primary cell-mediated cytotoxic response.
Ting CC; Rodgigues D; Bushar GS; Herberman RB
J Immunol; 1976 Jan; 116(1):236-43. PubMed ID: 54387
[TBL] [Abstract][Full Text] [Related]
4. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
[TBL] [Abstract][Full Text] [Related]
5. Cellular immune reactivity in vitro and tumor rejection provided by tumor-associated antigens of friend-virus-induced leukemia.
Dean JH; McCoy JL; Law LW; Maurer BA; Appella E
Int J Cancer; 1975 Nov; 16(5):701-12. PubMed ID: 1184239
[TBL] [Abstract][Full Text] [Related]
6. Suppression of tumor-specific cell-mediated cytotoxicity by immunoregulatory alpha-globulin and by immunoregulatory alpha-globulin-like peptides from cancer patients.
Wang BS; Badger AM; Nimberg RR; Cooperband SR; Schmid K; Mannick JA
Cancer Res; 1977 Sep; 37(9):3022-5. PubMed ID: 69489
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated immunity to friend virus-induced leukemia. IV. In vitro generation of primary and secondary cell-mediated cytotoxic responses.
Ting CC; Bonnard GD
J Immunol; 1976 May; 116(5):1419-25. PubMed ID: 58034
[TBL] [Abstract][Full Text] [Related]
8. Humoral regulation of cell-mediated immunity to syngeneic tumor.
Ting CC
Cancer Res; 1976 Oct; 36(10):3695-701. PubMed ID: 953995
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of leukemogenesis. I. Generation of autoreactive lymphocytes in response to a murine leukemia virus.
Schenk PJ; Howe ML
J Immunol; 1979 May; 122(5):1874-80. PubMed ID: 221580
[TBL] [Abstract][Full Text] [Related]
10. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen.
Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM
J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053
[TBL] [Abstract][Full Text] [Related]
11. In vitro generation of tumor-specific cytotoxic lymphocytes. Secondary allogeneic mixed tumor lymphocyte culture of normal murine spleen cells.
Gillis S; Smith KA
J Exp Med; 1977 Aug; 146(2):468-82. PubMed ID: 69003
[TBL] [Abstract][Full Text] [Related]
12. Afferent and efferent interference of cell-mediated cytotoxic reactions by heparin.
Ting CC
J Natl Cancer Inst; 1976 Aug; 57(2):455-7. PubMed ID: 1003523
[TBL] [Abstract][Full Text] [Related]
13. Generation of lytic and proliferative lymphoid clones to syngeneic tumor: in vitro and in vivo studies.
Rosenstein M; Rosenberg SA
J Natl Cancer Inst; 1984 May; 72(5):1161-5. PubMed ID: 6609266
[TBL] [Abstract][Full Text] [Related]
14. Cell-mediated immunity to Friend virus-induced leukemia. I. Modification of 125IUdR release cytotoxicity assay for use with suspension target cells.
Ting C-C ; Bushar GS; Rodrigues D; Herberman RB
J Immunol; 1975 Nov; 115(5):1351-6. PubMed ID: 170343
[TBL] [Abstract][Full Text] [Related]
15. Regulation of the in vitro secondary cell-mediated cytotoxic response against syngeneic FBL-3 leukemia by macrophages.
Igarashi T; Teranishi T; Rodrigues D; Yamamura Y
Microbiol Immunol; 1980; 24(6):599-72. PubMed ID: 6968022
[TBL] [Abstract][Full Text] [Related]
16. Generation of long-term T-lymphoid cell lines with specific cytotoxic reactivity for a syngeneic murine lymphoma.
Eberlein TJ; Rosenstein M; Spiess PJ; Rosenberg SA
J Natl Cancer Inst; 1982 Jul; 69(1):109-16. PubMed ID: 6980314
[TBL] [Abstract][Full Text] [Related]
17. Eradication of disseminated murine leukemia by treatment with high-dose interleukin 2.
Thompson JA; Peace DJ; Klarnet JP; Kern DE; Greenberg PD; Cheever MA
J Immunol; 1986 Dec; 137(11):3675-80. PubMed ID: 3491145
[TBL] [Abstract][Full Text] [Related]
18. Solubilized TSTA and the major viral structural proteins, gp70 and p30, in the immune response to murine leukemias induced by Friend and Rauscher virus.
Rogers MJ; Law LW; Appella E; Oroszlan S; Ting CC
Int J Cancer; 1977 Aug; 20(2):303-8. PubMed ID: 892937
[TBL] [Abstract][Full Text] [Related]
19. Eradication of disseminated murine leukemia by chemoimmunotherapy with cyclophosphamide and adoptively transferred immune syngeneic Lyt-1+2- lymphocytes.
Greenberg PD; Cheever MA; Fefer A
J Exp Med; 1981 Sep; 154(3):952-63. PubMed ID: 6974221
[TBL] [Abstract][Full Text] [Related]
20. Comparison of three isotopic assays of cell-mediated cytotoxicity against mouse tumor cells. II. Sensitivity and specificity of the assays and characteristics of effector and sensitizing cells.
Ting CC; Nunn ME; Park JY; Herberman RB
J Natl Cancer Inst; 1977 Feb; 58(2):331-7. PubMed ID: 833881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
